Invention Grant
- Patent Title: Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
- Patent Title (中): 静脉注射用乙酰水杨酸和茶氨酸的水溶性共晶体
-
Application No.: US13732807Application Date: 2013-01-02
-
Publication No.: US08476250B2Publication Date: 2013-07-02
- Inventor: Harry Brittain , Philip V. Felice
- Applicant: Theaprin Pharmaceuticals Inc.
- Applicant Address: US NY Hauppauge
- Assignee: Theaprin Pharmaceuticals Inc.
- Current Assignee: Theaprin Pharmaceuticals Inc.
- Current Assignee Address: US NY Hauppauge
- Agency: Notaro, Michalos & Zaccaria P.C.
- Main IPC: A61K31/60
- IPC: A61K31/60 ; A61K31/12
Abstract:
A method of treatment using a water-soluble cocrystal composition contains a quantity of acetylsalicylic acid and a quantity of a theanine enantiomer selected from an alpha variant of theanine or a beta variant of theanine or other form of theanine.
Public/Granted literature
- US20130123218A1 Intravenous Formulation with Water-soluble CoCrystals of Acetylsalicylic Acid and Theanine Public/Granted day:2013-05-16
Information query
